Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CDK1 | P06493 | 1/20 | 0.57 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | AMY2A | P04746 | 2/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Melibiose SCHEMBL4257775 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL20421903 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356838 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| SCHEMBL18650670 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL2354450 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL109659 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL24013212 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21114348 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356841 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356840 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070830-A | Yeast beta-glucan composition for preventing and relieving upper respiratory tract infection | 安琪酵母股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| CN-122060647-A | Bifidobacterium pseudocatenulatum and application thereof | 中粮营养健康研究院有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122004475-A | Nanometer suspension containing vitamin and mineral substances and preparation method thereof | 安琪酵母股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-3894018-B1 | TOPICAL, ISOTONIC COMPOSITIONS FOR GENITAL USE | GLYCIOME LLC (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260077003-A1 | LACTOBACILLUS REUTERI AND USE, COMPOSITION, DRUG AND FOOD THEREOF | WISBIOM (BEIJING) BIOTECHNOLOGY CO., LTD. (CN) | 2026-03-19 | — | — | US | claimed |
| EP-4700109-A1 | FERMENTED BEVERAGE AND METHOD FOR PRODUCING SAME | Asahi Group Holdings, Ltd. (JP) | 2026-02-25 | — | — | EP | claimed |
| EP-4691477-A2 | SYNBIOTIC COMPOSITION | Synbiotics AB (SE) | 2026-02-11 | — | — | EP | claimed |
| US-12544414-B2 | Lactobacillus reuteri and use, composition, drug and food thereof | WISBIOM (BEIJING) BIOTECHNOLOGY CO., LTD. (CN) | 2026-02-10 | — | — | US | claimed |
| EP-4034253-B1 | COMPOSITIONS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES | UNIV MICHIGAN REGENTS (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4243845-B1 | SYNBIOTIC COMPOSITION | SYNBIOTICS AB (SE) | 2026-01-07 | — | — | EP | claimed |
| CN-114009636-A | Noni enzyme compound juice and preparation method thereof | 海南懿然生物工程有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-113995124-A | Tricholoma matsutake seasoning and preparation method thereof | 山东美亿田科技有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113973966-A | Sea-buckthorn composite probiotic fruitcake and preparation method thereof | 山西农业大学 | 2022-01-28 | — | — | CN | claimed |
| CN-113974005-A | Ascorbic acid milk powder for breeding animals and using method | 河南普旺生物工程有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113993596-A | Cosmetic composition comprising a combination of at least one oligosaccharide and/or polysaccharide in combination with mannose monosaccharides and use thereof for maintaining the balance of the skin bacterial flora | 莱雅公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113974043-A | Prebiotics solid beverage and preparation method thereof | 山东星光首创生物科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113966795-A | Ginseng beverage and preparation method thereof | 深圳荣耀植物智能科学有限公司 | 2022-01-25 | — | — | CN | claimed |
| CN-113951413-A | Preparation method and application of hemophilus and phytophilus nitrogen source probiotic solid culture medium | 优仕康生（天津）科技发展有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113951518-A | High dietary fiber vegetable protein stick | 长光(滁州)高端智能装备研究院 | 2022-01-21 | — | — | CN | claimed |
| US-20190281874-A1 | OLIGOSACCHARIDES FOR FLAVOUR GENERATION | Société des Produits Nestlé S.A. (CH) | 2019-09-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077003-A1 | LACTOBACILLUS REUTERI AND USE, COMPOSITION, DRUG AND FOOD THEREOF | TPH1, TPH2, HTR2C | GAA 1631/4885CA2 2138/4885CDK1 2017/4885 |
| US-12544414-B2 | Lactobacillus reuteri and use, composition, drug and food thereof | SI, TREH, KYNU | GAA 591/4885CA2 2162/4885CDK1 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.